OR WAIT null SECS
January 02, 2016
Amid corporate restructurings, regulatory initiatives, and aging R&D assets, will drug development accelerate or stall in 2016?
Regulatory, corporate restructuring, and manufacturing issues will challenge bio/pharma to meet the needs and expectations of patients around the world.
December 14, 2015
The use of drug compounding facilities to produce over-priced generic drugs raises quality and regulatory questions.
December 02, 2015
Employers have work to do to improve job satisfaction and retain qualified workers.
Bio/pharma employee dissatisfaction with pay and progress may direct some to new career pathways.
The CEO of a US-based biosimilar manufacturer explains the legal and intellectual property issues of bringing a biosimilar to market in the United States.
Intellectual challenge, job security, and opportunity for advancement contribute to employee happiness, but the ultimate prize may be a satisfactory salary for bio/pharma employees in Europe.
November 02, 2015
The CPhI Pharma Awards celebrate innovations in the pharma industry.
August 25, 2015
Pfizer agrees to divest four sterile injectable assets to clear the way to complete acquisition of Hospira.